Clinical trials
Phase 1/2 Coronavirus Infections trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 4 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Apellis Pharmaceuticals, Inc. | 1 |
| Erasme University Hospital | 1 |
| Federal University of Minas Gerais | 1 |
| Regeneron Pharmaceuticals | 1 |
| University of Sao Paulo General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronavirus Infections | 5 |
| COVID-19 | 4 |
| Respiratory Distress Syndrome | 2 |
| Acute Lung Injury | 1 |
| Communicable Diseases | 1 |
| Inflammation | 1 |
| Respiratory Insufficiency | 1 |
| Respiratory Tract Infections | 1 |
| Severe Acute Respiratory Syndrome | 1 |
| Virus Diseases | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.